Pediatric Pertussis in Ambulatory Settings

Recruiting now

Conditions studied: Pertussis/Whooping Cough, Children, Only, Ambulatory

In brief

Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status).

Key facts

Study ID

NCT04807712

Run by

Association Clinique Thérapeutique Infantile du val de Marne

People needed

898

Starts

2001-05-30

Expected to finish

2030-01-01

Last updated by the study team

2024-02-08

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested

You may not qualify if…

• children without symptoms with a household confirmed case
• cases for which the pertussis diagnosis was not suspected by the pediatrician

Where it is running

• ACTIV — Créteil, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.